Actions - Pharma
Retour aux Propensions des Marchés Actions
Propensions (en %)Hausse 62%Neutre 15%Baisse 23%
| Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Absolu | Relatif | |||||||||||||||||||
| 113 | AstraZeneca | 12?322.8 | +++++ | +++++ | +++++ | + | * * | Pharma | 23.3 X | 2.2% | +++++ | +++++ | - - | ++++ | ++++ | ++++ | Neutre | AZN | BIG | |
| 112 | Lundbeck | 34.10 | +++++ | +++++ | +++++ | + | Pharma | 9.9 X | 2.0% | - - - - - | - - - - - | +++ | Neutre | +++ | HLUNB | MID | ||||
| 105 | Moderna | 121.2 | +++++ | +++++ | +++++ | + | Pharma | 16.6 X | 0.0% | - - - - - | +++ | - - - - - | - - - - - | - - - - - | ++++ | MRNA | BIG | |||
| 97 | UCB | 120.7 | +++++ | +++++ | +++++ | - | Pharma | 36.3 X | 1.5% | - - - - | - - | - - | Neutre | + | - - - | Neutre | UCB | BIG | ||
| 93 | Ipsen | 116.9 | +++++ | +++++ | ++++ | Neutre | * | Pharma | 14.8 X | 1.1% | - | - - - | ++++ | ++++ | ++++ | +++ | ++++ | IPN | MID | |
| 88 | EOG | 130.3 | +++++ | ++++ | ++++ | Neutre | * | Pharma | 8.1 X | 4.9% | + | +++++ | +++++ | +++++ | ++++ | EOG | BIG | |||
| 86 | GSK | 1?770.2 | +++++ | +++++ | +++++ | Neutre | * | Pharma | 12.4 X | 3.4% | - - - - | ++ | +++ | - - - | ++++ | ++++ | - | GSK | BIG | |
| 74 | Taux = + 25% | ++++ | +++++ | |||||||||||||||||
| 61 | Novo Nordisk | 889.9 | ++++ | ++++ | +++ | - | * | Pharma | 37.8 X | 1.1% | ++++ | - - | +++++ | +++++ | +++++ | +++++ | +++ | NOVOB | BIG | |
| 57 | Sanofi | 93.40 | +++ | +++ | ++ | Neutre | Pharma | 15.5 X | 4.2% | Neutre | - | - - | ++ | +++ | Neutre | ++ | SAN | BIG | ||
| 56 | Taux = + 15% | +++ | +++++ | |||||||||||||||||
| 55 | Hikma Pharm. | 1?967.4 | +++ | +++ | ++ | Neutre | * | Pharma | 11.5 X | 2.6% | +++ | ++++ | +++ | +++ | Neutre | HIK | MID | |||
| 50 | Amgen | 300.6 | +++ | +++ | ++ | Neutre | Pharma | 24.2 X | 3.1% | - - | ++++ | ++ | +++++ | +++++ | ++++ | - - - | AMGN | BIG | ||
| 47 | Eli Lilly | 777.5 | +++ | +++ | ++ | - | Pharma | 56.3 X | 0.6% | +++++ | +++++ | ++++ | +++++ | ++++ | +++++ | ++ | LLY | BIG | ||
| 45 | Taux = + 10% | +++ | +++++ | |||||||||||||||||
| 45 | Merck | 130.3 | +++ | +++ | ++ | Neutre | * | Pharma | 16.8 X | 2.2% | +++++ | +++++ | - | ++ | +++++ | +++++ | ++ | MRK | BIG | |
| 33 | Novartis AG | 90.60 | ++ | +++ | Neutre | Neutre | Pharma | 18.2 X | 3.7% | - - - - | ++ | - - - - - | - - - - | ++++ | ++++ | ++ | NOVN | BIG | ||
| 29 | Roche | 241.6 | ++ | ++ | Neutre | Neutre | Pharma | 13.7 X | 4.1% | + | - - - | Neutre | - - - - | ++++ | +++++ | ++ | ROG | BIG | ||
| 23 | Taux = + 5% | + | +++ | |||||||||||||||||
| 17 | Tx ESTER j/j rate | + | ++ | |||||||||||||||||
| 16 | Merck KG | 155.7 | + | + | - | Neutre | Pharma | 23.1 X | 1.4% | Neutre | ++++ | - | - | ++ | Neutre | - - | MRK | BIG | ||
| 9 | Virbac | 349.9 | Neutre | + | - | Neutre | Pharma | 20.7 X | 0.5% | ++ | +++ | ++++ | +++ | Neutre | ++ | ++++ | VIRP | Small | ||
| 7 | Recordati | 51.00 | Neutre | + | - - | Neutre | Pharma | 18.1 X | 2.8% | +++ | +++ | ++++ | +++++ | - | REC | MID | ||||
| 4 | Bayer | 28.50 | Neutre | Neutre | - | + | Pharma | 9.3 X | 7.7% | - - - - | Neutre | - - - - | - - | Neutre | - | - - - - - | BAYN | BIG | ||
| 0 | Taux ZERO | Neutre | Neutre | |||||||||||||||||
| -8 | Pfizer | 27.80 | Neutre | - | - - - | Neutre | Pharma | 16.4 X | 6.4% | - - - - - | - - - | - - - | - - - - - | +++ | - | - - - | PFE | BIG | ||
| -14 | Orion | 36.80 | - | - | - - | Neutre | Pharma | 22.2 X | 4.0% | - - - | Neutre | +++ | ++++ | ++++ | ORNBV | MID | ||||
| -54 | Boiron | 34.00 | - - - | - - - | - - - | Neutre | Pharma | 15.5 X | 2.4% | ++ | + | - - - | Neutre | - | - - - | +++++ | BOI | Small | ||
| -56 | Taux = - 5% | - - - | - - - | |||||||||||||||||
| -59 | Vetoquinol | 95.50 | - - - | - - - | - - - - - | Neutre | Pharma | 20.2 X | 0.9% | - | Neutre | ++ | Neutre | + | - | +++++ | VETO | Small | ||
| -61 | Takeda Pharma | 4?045.5 | - - - - | - - - | - - - - - | Neutre | Pharma | 9.1 X | 4.0% | +++ | Neutre | ++++ | - - - - | - - - | 4 502 | BIG | ||||
| -72 | Johnson & John. | 148.5 | - - - - | - - - - | - - - - - | Neutre | Pharma | 17.5 X | 3.0% | - - - - | ++++ | ++ | - - - | ++++ | +++++ | ++++ | JNJ | BIG | ||
| -77 | Astellas Pharma | 1?546.3 | - - - - | - - - - | - - - - - | Neutre | Pharma | 12.7 X | 3.6% | +++++ | +++ | ++ | ++ | ++++ | 4 503 | BIG | ||||